SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14C - Information statements:
SEC Accession No. 0001662252-17-000033
Filing Date
2017-03-01
Accepted
2017-03-01 10:52:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRER14C rchaprer14c.htm PRER14C 86621
2 filename2.htm CORRESP 6926
  Complete submission text file 0001662252-17-000033.txt   94642
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (323) 424-3169
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: PRER14C | Act: 34 | File No.: 000-54767 | Film No.: 17652155
SIC: 2834 Pharmaceutical Preparations